Selected research
Market Structure
Global Biologics Process Development Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Biologics Process Development Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Biologics Process Development Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Biologics Process Development Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Biologics Process Development Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Biologics Process Development Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Biologics Process Development Service include AGC Biologics, Bora Biologics, Canton Biologics, Catalent Biologics, Evotec, HIPRA, Kemwell Pharma, Lonza and Mabion, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Biologics Process Development Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Biologics Process Development Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Biologics Process Development Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Biologics Process Development Service market size, projected growth trends, production technologies, key applications, and end-use industries.
Biologics Process Development Service Segment by Company
AGC Biologics
Bora Biologics
Canton Biologics
Catalent Biologics
Evotec
HIPRA
Kemwell Pharma
Lonza
Mabion
NorthX Biologics
Pace Analytical
Rodon Biologics
Samsung Biologics
Sartorius
Thermo Fisher Scientific
WuXi Biologics
Biologics Process Development Service Segment by Type
R&D Scale (1-3L)
Pilot and Scale-Up (50-500L)
Clinical and Commercial Production Scale (1000L and Above)
Biologics Process Development Service Segment by Application
Contract Development and Manufacturing Organization (CDMO)
Professional Technical Service Provider
Large Pharmaceutical Company
Research Institute
Biologics Process Development Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biologics Process Development Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biologics Process Development Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biologics Process Development Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Biologics Process Development Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biologics Process Development Service industry.
Chapter 3: Detailed analysis of Biologics Process Development Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biologics Process Development Servicerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- R&D Scale (1-3L)
- Pilot and Scale-Up (50-500L)
- Clinical and Commercial Production Scale (1000L and Above)
Applications
- Contract Development and Manufacturing Organization (CDMO)
- Professional Technical Service Provider
- Large Pharmaceutical Company
- Research Institute
Companies covered
- AGC Biologics
- Bora Biologics
- Canton Biologics
- Catalent Biologics
- Evotec
- HIPRA
- Kemwell Pharma
- Lonza
- Mabion
- NorthX Biologics
- Pace Analytical
- Rodon Biologics
- Samsung Biologics
- Sartorius
- Thermo Fisher Scientific
- WuXi Biologics
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Biologics Process Development Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 R&D Scale (1-3L)
- 1.2.3 Pilot and Scale-Up (50-500L)
- 1.2.4 Clinical and Commercial Production Scale (1000L and Above)
- 1.3 Market Analysis by Application
- 1.3.1 Global Biologics Process Development Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Contract Development and Manufacturing Organization (CDMO)
- 1.3.3 Professional Technical Service Provider
- 1.3.4 Large Pharmaceutical Company
- 1.3.5 Research Institute
- 1.4 Global Market Growth Prospects
- 1.5 Global Biologics Process Development Service Growth Trends by Region
- 1.5.1 Global Biologics Process Development Service Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Biologics Process Development Service Market Size by Region (2021-2026)
- 1.5.3 Biologics Process Development Service Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Biologics Process Development Service Market Dynamics
- 2.1 Biologics Process Development Service Industry Trends
- 2.2 Biologics Process Development Service Industry Drivers
- 2.3 Biologics Process Development Service Industry Opportunities and Challenges
- 2.4 Biologics Process Development Service Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Biologics Process Development Service Revenue by Company (2021-2026)
- 3.2 Global Biologics Process Development Service Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Biologics Process Development Service Key Company Head office and Area Served
- 3.4 Global Biologics Process Development Service Company, Product Type & Application
- 3.5 Global Biologics Process Development Service Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Biologics Process Development Service Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Biologics Process Development Service Players Market Share by Revenue in 2025
- 3.6.3 2025 Biologics Process Development Service Tier 1, Tier 2, and Tier 3
4 Biologics Process Development Service Market by Type
- 4.1 Global Biologics Process Development Service Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Biologics Process Development Service Market Size by Type (2021-2032)
- 4.3 Global Biologics Process Development Service Market Size Share by Type (2021-2032)
5 Biologics Process Development Service Market by Application
- 5.1 Global Biologics Process Development Service Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Biologics Process Development Service Market Size by Application (2021-2032)
- 5.3 Global Biologics Process Development Service Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 AGC Biologics
- 6.1.1 AGC Biologics Company Information
- 6.1.2 AGC Biologics Business Overview
- 6.1.3 AGC Biologics Biologics Process Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 AGC Biologics Biologics Process Development Service Product Portfolio
- 6.1.5 AGC Biologics Recent Developments
- 6.2 Bora Biologics
- 6.2.1 Bora Biologics Company Information
- 6.2.2 Bora Biologics Business Overview
- 6.2.3 Bora Biologics Biologics Process Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Bora Biologics Biologics Process Development Service Product Portfolio
- 6.2.5 Bora Biologics Recent Developments
- 6.3 Canton Biologics
- 6.3.1 Canton Biologics Company Information
- 6.3.2 Canton Biologics Business Overview
- 6.3.3 Canton Biologics Biologics Process Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Canton Biologics Biologics Process Development Service Product Portfolio
- 6.3.5 Canton Biologics Recent Developments
- 6.4 Catalent Biologics
- 6.4.1 Catalent Biologics Company Information
- 6.4.2 Catalent Biologics Business Overview
- 6.4.3 Catalent Biologics Biologics Process Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Catalent Biologics Biologics Process Development Service Product Portfolio
- 6.4.5 Catalent Biologics Recent Developments
- 6.5 Evotec
- 6.5.1 Evotec Company Information
- 6.5.2 Evotec Business Overview
- 6.5.3 Evotec Biologics Process Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Evotec Biologics Process Development Service Product Portfolio
- 6.5.5 Evotec Recent Developments
- 6.6 HIPRA
- 6.6.1 HIPRA Company Information
- 6.6.2 HIPRA Business Overview
- 6.6.3 HIPRA Biologics Process Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 HIPRA Biologics Process Development Service Product Portfolio
- 6.6.5 HIPRA Recent Developments
- 6.7 Kemwell Pharma
- 6.7.1 Kemwell Pharma Company Information
- 6.7.2 Kemwell Pharma Business Overview
- 6.7.3 Kemwell Pharma Biologics Process Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Kemwell Pharma Biologics Process Development Service Product Portfolio
- 6.7.5 Kemwell Pharma Recent Developments
- 6.8 Lonza
- 6.8.1 Lonza Company Information
- 6.8.2 Lonza Business Overview
- 6.8.3 Lonza Biologics Process Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Lonza Biologics Process Development Service Product Portfolio
- 6.8.5 Lonza Recent Developments
- 6.9 Mabion
- 6.9.1 Mabion Company Information
- 6.9.2 Mabion Business Overview
- 6.9.3 Mabion Biologics Process Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Mabion Biologics Process Development Service Product Portfolio
- 6.9.5 Mabion Recent Developments
- 6.10 NorthX Biologics
- 6.10.1 NorthX Biologics Company Information
- 6.10.2 NorthX Biologics Business Overview
- 6.10.3 NorthX Biologics Biologics Process Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 NorthX Biologics Biologics Process Development Service Product Portfolio
- 6.10.5 NorthX Biologics Recent Developments
- 6.11 Pace Analytical
- 6.11.1 Pace Analytical Company Information
- 6.11.2 Pace Analytical Business Overview
- 6.11.3 Pace Analytical Biologics Process Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Pace Analytical Biologics Process Development Service Product Portfolio
- 6.11.5 Pace Analytical Recent Developments
- 6.12 Rodon Biologics
- 6.12.1 Rodon Biologics Company Information
- 6.12.2 Rodon Biologics Business Overview
- 6.12.3 Rodon Biologics Biologics Process Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Rodon Biologics Biologics Process Development Service Product Portfolio
- 6.12.5 Rodon Biologics Recent Developments
- 6.13 Samsung Biologics
- 6.13.1 Samsung Biologics Company Information
- 6.13.2 Samsung Biologics Business Overview
- 6.13.3 Samsung Biologics Biologics Process Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Samsung Biologics Biologics Process Development Service Product Portfolio
- 6.13.5 Samsung Biologics Recent Developments
- 6.14 Sartorius
- 6.14.1 Sartorius Company Information
- 6.14.2 Sartorius Business Overview
- 6.14.3 Sartorius Biologics Process Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Sartorius Biologics Process Development Service Product Portfolio
- 6.14.5 Sartorius Recent Developments
- 6.15 Thermo Fisher Scientific
- 6.15.1 Thermo Fisher Scientific Company Information
- 6.15.2 Thermo Fisher Scientific Business Overview
- 6.15.3 Thermo Fisher Scientific Biologics Process Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Thermo Fisher Scientific Biologics Process Development Service Product Portfolio
- 6.15.5 Thermo Fisher Scientific Recent Developments
- 6.16 WuXi Biologics
- 6.16.1 WuXi Biologics Company Information
- 6.16.2 WuXi Biologics Business Overview
- 6.16.3 WuXi Biologics Biologics Process Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 WuXi Biologics Biologics Process Development Service Product Portfolio
- 6.16.5 WuXi Biologics Recent Developments
7 North America
- 7.1 North America Biologics Process Development Service Market Size (2021-2032)
- 7.2 North America Biologics Process Development Service Market Size by Type
- 7.2.1 North America Biologics Process Development Service Market Size by Type (2021-2026)
- 7.2.2 North America Biologics Process Development Service Market Size by Type (2027-2032)
- 7.2.3 North America Biologics Process Development Service Market Share by Type (2021-2032)
- 7.3 North America Biologics Process Development Service Market Size by Application
- 7.3.1 North America Biologics Process Development Service Market Size by Application (2021-2026)
- 7.3.2 North America Biologics Process Development Service Market Size by Application (2027-2032)
- 7.3.3 North America Biologics Process Development Service Market Share by Application (2021-2032)
- 7.4 North America Biologics Process Development Service Market Size by Country
- 7.4.1 North America Biologics Process Development Service Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Biologics Process Development Service Market Size by Country (2021-2026)
- 7.4.3 North America Biologics Process Development Service Market Size by Country (2027-2032)
- 7.4.4 North America Biologics Process Development Service Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Biologics Process Development Service Market Size (2021-2032)
- 8.2 Europe Biologics Process Development Service Market Size by Type
- 8.2.1 Europe Biologics Process Development Service Market Size by Type (2021-2026)
- 8.2.2 Europe Biologics Process Development Service Market Size by Type (2027-2032)
- 8.2.3 Europe Biologics Process Development Service Market Share by Type (2021-2032)
- 8.3 Europe Biologics Process Development Service Market Size by Application
- 8.3.1 Europe Biologics Process Development Service Market Size by Application (2021-2026)
- 8.3.2 Europe Biologics Process Development Service Market Size by Application (2027-2032)
- 8.3.3 Europe Biologics Process Development Service Market Share by Application (2021-2032)
- 8.4 Europe Biologics Process Development Service Market Size by Country
- 8.4.1 Europe Biologics Process Development Service Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Biologics Process Development Service Market Size by Country (2021-2026)
- 8.4.3 Europe Biologics Process Development Service Market Size by Country (2027-2032)
- 8.4.4 Europe Biologics Process Development Service Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Biologics Process Development Service Market Size (2021-2032)
- 9.2 China Biologics Process Development Service Market Size by Type
- 9.2.1 China Biologics Process Development Service Market Size by Type (2021-2026)
- 9.2.2 China Biologics Process Development Service Market Size by Type (2027-2032)
- 9.2.3 China Biologics Process Development Service Market Share by Type (2021-2032)
- 9.3 China Biologics Process Development Service Market Size by Application
- 9.3.1 China Biologics Process Development Service Market Size by Application (2021-2026)
- 9.3.2 China Biologics Process Development Service Market Size by Application (2027-2032)
- 9.3.3 China Biologics Process Development Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Biologics Process Development Service Market Size (2021-2032)
- 10.2 Asia Biologics Process Development Service Market Size by Type
- 10.2.1 Asia Biologics Process Development Service Market Size by Type (2021-2026)
- 10.2.2 Asia Biologics Process Development Service Market Size by Type (2027-2032)
- 10.2.3 Asia Biologics Process Development Service Market Share by Type (2021-2032)
- 10.3 Asia Biologics Process Development Service Market Size by Application
- 10.3.1 Asia Biologics Process Development Service Market Size by Application (2021-2026)
- 10.3.2 Asia Biologics Process Development Service Market Size by Application (2027-2032)
- 10.3.3 Asia Biologics Process Development Service Market Share by Application (2021-2032)
- 10.4 Asia Biologics Process Development Service Market Size by Country
- 10.4.1 Asia Biologics Process Development Service Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Biologics Process Development Service Market Size by Country (2021-2026)
- 10.4.3 Asia Biologics Process Development Service Market Size by Country (2027-2032)
- 10.4.4 Asia Biologics Process Development Service Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Biologics Process Development Service Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Biologics Process Development Service Market Size by Type
- 11.2.1 South America, Middle East & Africa Biologics Process Development Service Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Biologics Process Development Service Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Biologics Process Development Service Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Biologics Process Development Service Market Size by Application
- 11.3.1 South America, Middle East & Africa Biologics Process Development Service Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Biologics Process Development Service Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Biologics Process Development Service Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Biologics Process Development Service Market Size by Country
- 11.4.1 South America, Middle East & Africa Biologics Process Development Service Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Biologics Process Development Service Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Biologics Process Development Service Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Biologics Process Development Service Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst